Behind the Mystery™ is a recurring series on The Balancing Act® devoted to advocating for rare and genetic diseases.
Egetis is the proud sponsor of the MCT8 Deficiency episode of Behind the Mystery. Click here to watch the full episode.
Nickie, a devoted mom, caregiver, and advocate for her son, Liam, with MCT8 deficiency, shares the emotional story of finally receiving his diagnosis.
Watch VideoAndrew J. Bauer, MD, discusses the paths to an MCT8 diagnosis.
Watch VideoAnny Bedard, President North America, Egetis Therapeutics, discusses the importance of working together to address the unmet needs of MCT8 deficiency patients.
Watch Video
”
Egetis is driven by three key pillars: Courage, Commitment and Collaboration. We have the courage to tackle hard conditions like MCT8 deficiency, commitment to uphold the highest ethical standards, and value ongoing collaboration with the MCT8 community to heighten awareness and understanding of MCT8 deficiency. Currently, there are no approved medicines for MCT8 deficiency in the United States, creating a high unmet need we’re diligently working to address.
Anny Bedard, President North America, Egetis Therapeutics